What Is Oxazepam? Drug Class, Schedule & Drug Test Answers

Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated September 2026

Quick answer: Oxazepam is a Benzodiazepine (GABA-A modulator). Schedule IV by prescription. Here's how the drug is classified, whether it's a narcotic/controlled substance, and what that means for testing.

What is Oxazepam?

Drug class: Benzodiazepine (GABA-A modulator)

Federal schedule: Schedule IV by prescription.

Oxazepam is the calibrator compound for most benzodiazepine immunoassays — cutoffs are quoted in 'oxazepam equivalents.' That makes it one of the most reliably detected benzos on 10/12-panel strips.

Is Oxazepam a narcotic?

It is classified as a narcotic under the DEA's federal schedule. What matters more for you: Schedule IV by prescription..

Does it show up on drug tests?

No — it is not on the standard 5-panel; it appears only on expanded or panel-specific orders. See the full Oxazepam drug test guide for detection windows and cutoffs.

False-positive caution

  • Sertraline and oxaprozin have documented case-report false positives for benzodiazepine immunoassays (class-wide).

Certified labs nationwide · Results in 1–2 days

Need a test? Order online, test same-day →
Medical disclaimer: DrugPanels provides educational information about laboratory drug testing and does not offer medical advice, diagnosis, or treatment. Detection windows are population ranges — individual results vary with metabolism, dose, frequency and health status. Never stop prescribed medication to pass a test without talking to your prescriber. Affiliate disclosure: some links on this page are affiliate links; if you order through them we may earn a commission at no additional cost to you.

People also ask

Do prescriptions count against me?

No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.

Sources & further reading

  • SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
  • DOT — 49 CFR Part 40 procedures for transportation workplace testing
  • Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
  • FDA — drug-of-abuse test device labeling (detection window conventions)